Pre-Type 1 Diabetes Dysmetabolism: Maximal Sensitivity Achieved with Both Oral and Intravenous Glucose Tolerance Testing
- 31 January 2007
- journal article
- research article
- Published by Elsevier
- Vol. 150 (1) , 31-36.e6
- https://doi.org/10.1016/j.jpeds.2006.09.033
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Dose-dense and high-dose chemotherapy plus rituximab with autologous stem cell transplantation for primary treatment of diffuse large B-cell lymphoma with a poor prognosis: a phase II multicenter studyHaematologica, 2009
- Revised Response Criteria for Malignant LymphomaJournal of Clinical Oncology, 2007
- Is there a place for routine imaging for patients in complete remission from aggressive lymphoma?Annals of Oncology, 2006
- Randomised phase III study of R-ICE versus R-DHAP in relapsed patients with CD20 diffuse large B-cell lymphoma (DLBCL) followed by high-dose therapy and a second randomisation to maintenance treatment with rituximab or not: an update of the CORAL studyAnnals of Oncology, 2006
- Insulin resistance in type 1 diabetesDiabetes/Metabolism Research and Reviews, 2002
- Changing trends in the incidence of non-Hodgkin's lymphoma in EuropeAnnals of Oncology, 1997
- Autologous Bone Marrow Transplantation as Compared with Salvage Chemotherapy in Relapses of Chemotherapy-Sensitive Non-Hodgkin's LymphomaNew England Journal of Medicine, 1995
- First-phase insulin release in normal childrenThe Journal of Pediatrics, 1993
- TEN-YEAR FOLLOW-UP STUDY OF ISLET-CELL ANTIBODIES AND CHILDHOOD DIABETES MELLITUSThe Lancet, 1989
- Ten-year prognosis of impaired glucose tolerance in siblings of patients with insulin-dependent diabetesDiabetes, 1982